Global Pain Management Drugs & Devices Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Pain Management Drugs & Devices Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Page: 113

Published Date: 02 Jan 2025

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Pain Management Drugs & Devices market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report is a detailed and comprehensive analysis for global Pain Management Drugs & Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Pain Management Drugs & Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pain Management Drugs & Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pain Management Drugs & Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pain Management Drugs & Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pain Management Drugs & Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pain Management Drugs & Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbvie Inc., Astrazeneca Depomed Inc., Djo Global Inc., Eli Lilly & Co., Endo International, Glaxosmithkline, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic Inc., Novartis International Ag, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Pain Management Drugs & Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Pharmaceuticals
Devices

Market segment by Application
Burn Pain
Cancer Pain
Dental/Facial Pain
Migraine Headache Pain
Musculoskeletal Pain
Neuropathic Pain
Obstetrical Pain

Major players covered
Abbvie Inc.
Astrazeneca Depomed Inc.
Djo Global Inc.
Eli Lilly & Co.
Endo International
Glaxosmithkline
Hisamitsu Pharmaceutical Co. Inc.
Johnson & Johnson
Medtronic Inc.
Novartis International Ag
Pfizer
Purdue Pharmaceuticals Lp
Abbott

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pain Management Drugs & Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pain Management Drugs & Devices, with price, sales quantity, revenue, and global market share of Pain Management Drugs & Devices from 2020 to 2025.
Chapter 3, the Pain Management Drugs & Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pain Management Drugs & Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pain Management Drugs & Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pain Management Drugs & Devices.
Chapter 14 and 15, to describe Pain Management Drugs & Devices sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pain Management Drugs & Devices Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Pharmaceuticals
1.3.3 Devices
1.4 Market Analysis by Application
1.4.1 Overview: Global Pain Management Drugs & Devices Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Burn Pain
1.4.3 Cancer Pain
1.4.4 Dental/Facial Pain
1.4.5 Migraine Headache Pain
1.4.6 Musculoskeletal Pain
1.4.7 Neuropathic Pain
1.4.8 Obstetrical Pain
1.5 Global Pain Management Drugs & Devices Market Size & Forecast
1.5.1 Global Pain Management Drugs & Devices Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Pain Management Drugs & Devices Sales Quantity (2020-2031)
1.5.3 Global Pain Management Drugs & Devices Average Price (2020-2031)

2 Manufacturers Profiles
2.1 Abbvie Inc.
2.1.1 Abbvie Inc. Details
2.1.2 Abbvie Inc. Major Business
2.1.3 Abbvie Inc. Pain Management Drugs & Devices Product and Services
2.1.4 Abbvie Inc. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Abbvie Inc. Recent Developments/Updates
2.2 Astrazeneca Depomed Inc.
2.2.1 Astrazeneca Depomed Inc. Details
2.2.2 Astrazeneca Depomed Inc. Major Business
2.2.3 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Product and Services
2.2.4 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Astrazeneca Depomed Inc. Recent Developments/Updates
2.3 Djo Global Inc.
2.3.1 Djo Global Inc. Details
2.3.2 Djo Global Inc. Major Business
2.3.3 Djo Global Inc. Pain Management Drugs & Devices Product and Services
2.3.4 Djo Global Inc. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Djo Global Inc. Recent Developments/Updates
2.4 Eli Lilly & Co.
2.4.1 Eli Lilly & Co. Details
2.4.2 Eli Lilly & Co. Major Business
2.4.3 Eli Lilly & Co. Pain Management Drugs & Devices Product and Services
2.4.4 Eli Lilly & Co. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Eli Lilly & Co. Recent Developments/Updates
2.5 Endo International
2.5.1 Endo International Details
2.5.2 Endo International Major Business
2.5.3 Endo International Pain Management Drugs & Devices Product and Services
2.5.4 Endo International Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Endo International Recent Developments/Updates
2.6 Glaxosmithkline
2.6.1 Glaxosmithkline Details
2.6.2 Glaxosmithkline Major Business
2.6.3 Glaxosmithkline Pain Management Drugs & Devices Product and Services
2.6.4 Glaxosmithkline Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Glaxosmithkline Recent Developments/Updates
2.7 Hisamitsu Pharmaceutical Co. Inc.
2.7.1 Hisamitsu Pharmaceutical Co. Inc. Details
2.7.2 Hisamitsu Pharmaceutical Co. Inc. Major Business
2.7.3 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Product and Services
2.7.4 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Hisamitsu Pharmaceutical Co. Inc. Recent Developments/Updates
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Pain Management Drugs & Devices Product and Services
2.8.4 Johnson & Johnson Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Johnson & Johnson Recent Developments/Updates
2.9 Medtronic Inc.
2.9.1 Medtronic Inc. Details
2.9.2 Medtronic Inc. Major Business
2.9.3 Medtronic Inc. Pain Management Drugs & Devices Product and Services
2.9.4 Medtronic Inc. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Medtronic Inc. Recent Developments/Updates
2.10 Novartis International Ag
2.10.1 Novartis International Ag Details
2.10.2 Novartis International Ag Major Business
2.10.3 Novartis International Ag Pain Management Drugs & Devices Product and Services
2.10.4 Novartis International Ag Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Novartis International Ag Recent Developments/Updates
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Pain Management Drugs & Devices Product and Services
2.11.4 Pfizer Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Pfizer Recent Developments/Updates
2.12 Purdue Pharmaceuticals Lp
2.12.1 Purdue Pharmaceuticals Lp Details
2.12.2 Purdue Pharmaceuticals Lp Major Business
2.12.3 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Product and Services
2.12.4 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Purdue Pharmaceuticals Lp Recent Developments/Updates
2.13 Abbott
2.13.1 Abbott Details
2.13.2 Abbott Major Business
2.13.3 Abbott Pain Management Drugs & Devices Product and Services
2.13.4 Abbott Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Abbott Recent Developments/Updates

3 Competitive Environment: Pain Management Drugs & Devices by Manufacturer
3.1 Global Pain Management Drugs & Devices Sales Quantity by Manufacturer (2020-2025)
3.2 Global Pain Management Drugs & Devices Revenue by Manufacturer (2020-2025)
3.3 Global Pain Management Drugs & Devices Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Pain Management Drugs & Devices by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Pain Management Drugs & Devices Manufacturer Market Share in 2024
3.4.3 Top 6 Pain Management Drugs & Devices Manufacturer Market Share in 2024
3.5 Pain Management Drugs & Devices Market: Overall Company Footprint Analysis
3.5.1 Pain Management Drugs & Devices Market: Region Footprint
3.5.2 Pain Management Drugs & Devices Market: Company Product Type Footprint
3.5.3 Pain Management Drugs & Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Pain Management Drugs & Devices Market Size by Region
4.1.1 Global Pain Management Drugs & Devices Sales Quantity by Region (2020-2031)
4.1.2 Global Pain Management Drugs & Devices Consumption Value by Region (2020-2031)
4.1.3 Global Pain Management Drugs & Devices Average Price by Region (2020-2031)
4.2 North America Pain Management Drugs & Devices Consumption Value (2020-2031)
4.3 Europe Pain Management Drugs & Devices Consumption Value (2020-2031)
4.4 Asia-Pacific Pain Management Drugs & Devices Consumption Value (2020-2031)
4.5 South America Pain Management Drugs & Devices Consumption Value (2020-2031)
4.6 Middle East & Africa Pain Management Drugs & Devices Consumption Value (2020-2031)

5 Market Segment by Type
5.1 Global Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
5.2 Global Pain Management Drugs & Devices Consumption Value by Type (2020-2031)
5.3 Global Pain Management Drugs & Devices Average Price by Type (2020-2031)

6 Market Segment by Application
6.1 Global Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
6.2 Global Pain Management Drugs & Devices Consumption Value by Application (2020-2031)
6.3 Global Pain Management Drugs & Devices Average Price by Application (2020-2031)

7 North America
7.1 North America Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
7.2 North America Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
7.3 North America Pain Management Drugs & Devices Market Size by Country
7.3.1 North America Pain Management Drugs & Devices Sales Quantity by Country (2020-2031)
7.3.2 North America Pain Management Drugs & Devices Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe
8.1 Europe Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
8.2 Europe Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
8.3 Europe Pain Management Drugs & Devices Market Size by Country
8.3.1 Europe Pain Management Drugs & Devices Sales Quantity by Country (2020-2031)
8.3.2 Europe Pain Management Drugs & Devices Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific
9.1 Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Pain Management Drugs & Devices Market Size by Region
9.3.1 Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Pain Management Drugs & Devices Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America
10.1 South America Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
10.2 South America Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
10.3 South America Pain Management Drugs & Devices Market Size by Country
10.3.1 South America Pain Management Drugs & Devices Sales Quantity by Country (2020-2031)
10.3.2 South America Pain Management Drugs & Devices Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa
11.1 Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Pain Management Drugs & Devices Market Size by Country
11.3.1 Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Pain Management Drugs & Devices Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics
12.1 Pain Management Drugs & Devices Market Drivers
12.2 Pain Management Drugs & Devices Market Restraints
12.3 Pain Management Drugs & Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Pain Management Drugs & Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pain Management Drugs & Devices
13.3 Pain Management Drugs & Devices Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pain Management Drugs & Devices Typical Distributors
14.3 Pain Management Drugs & Devices Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Pain Management Drugs & Devices Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Pain Management Drugs & Devices Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Abbvie Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Abbvie Inc. Major Business
Table 5. Abbvie Inc. Pain Management Drugs & Devices Product and Services
Table 6. Abbvie Inc. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Abbvie Inc. Recent Developments/Updates
Table 8. Astrazeneca Depomed Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Astrazeneca Depomed Inc. Major Business
Table 10. Astrazeneca Depomed Inc. Pain Management Drugs & Devices Product and Services
Table 11. Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Astrazeneca Depomed Inc. Recent Developments/Updates
Table 13. Djo Global Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Djo Global Inc. Major Business
Table 15. Djo Global Inc. Pain Management Drugs & Devices Product and Services
Table 16. Djo Global Inc. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Djo Global Inc. Recent Developments/Updates
Table 18. Eli Lilly & Co. Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly & Co. Major Business
Table 20. Eli Lilly & Co. Pain Management Drugs & Devices Product and Services
Table 21. Eli Lilly & Co. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Eli Lilly & Co. Recent Developments/Updates
Table 23. Endo International Basic Information, Manufacturing Base and Competitors
Table 24. Endo International Major Business
Table 25. Endo International Pain Management Drugs & Devices Product and Services
Table 26. Endo International Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Endo International Recent Developments/Updates
Table 28. Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table 29. Glaxosmithkline Major Business
Table 30. Glaxosmithkline Pain Management Drugs & Devices Product and Services
Table 31. Glaxosmithkline Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Glaxosmithkline Recent Developments/Updates
Table 33. Hisamitsu Pharmaceutical Co. Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Hisamitsu Pharmaceutical Co. Inc. Major Business
Table 35. Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Product and Services
Table 36. Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Hisamitsu Pharmaceutical Co. Inc. Recent Developments/Updates
Table 38. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 39. Johnson & Johnson Major Business
Table 40. Johnson & Johnson Pain Management Drugs & Devices Product and Services
Table 41. Johnson & Johnson Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Johnson & Johnson Recent Developments/Updates
Table 43. Medtronic Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Medtronic Inc. Major Business
Table 45. Medtronic Inc. Pain Management Drugs & Devices Product and Services
Table 46. Medtronic Inc. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Medtronic Inc. Recent Developments/Updates
Table 48. Novartis International Ag Basic Information, Manufacturing Base and Competitors
Table 49. Novartis International Ag Major Business
Table 50. Novartis International Ag Pain Management Drugs & Devices Product and Services
Table 51. Novartis International Ag Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Novartis International Ag Recent Developments/Updates
Table 53. Pfizer Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Major Business
Table 55. Pfizer Pain Management Drugs & Devices Product and Services
Table 56. Pfizer Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Pfizer Recent Developments/Updates
Table 58. Purdue Pharmaceuticals Lp Basic Information, Manufacturing Base and Competitors
Table 59. Purdue Pharmaceuticals Lp Major Business
Table 60. Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Product and Services
Table 61. Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Purdue Pharmaceuticals Lp Recent Developments/Updates
Table 63. Abbott Basic Information, Manufacturing Base and Competitors
Table 64. Abbott Major Business
Table 65. Abbott Pain Management Drugs & Devices Product and Services
Table 66. Abbott Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Abbott Recent Developments/Updates
Table 68. Global Pain Management Drugs & Devices Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 69. Global Pain Management Drugs & Devices Revenue by Manufacturer (2020-2025) & (USD Million)
Table 70. Global Pain Management Drugs & Devices Average Price by Manufacturer (2020-2025) & (USD/Unit)
Table 71. Market Position of Manufacturers in Pain Management Drugs & Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 72. Head Office and Pain Management Drugs & Devices Production Site of Key Manufacturer
Table 73. Pain Management Drugs & Devices Market: Company Product Type Footprint
Table 74. Pain Management Drugs & Devices Market: Company Product Application Footprint
Table 75. Pain Management Drugs & Devices New Market Entrants and Barriers to Market Entry
Table 76. Pain Management Drugs & Devices Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Pain Management Drugs & Devices Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 78. Global Pain Management Drugs & Devices Sales Quantity by Region (2020-2025) & (K Units)
Table 79. Global Pain Management Drugs & Devices Sales Quantity by Region (2026-2031) & (K Units)
Table 80. Global Pain Management Drugs & Devices Consumption Value by Region (2020-2025) & (USD Million)
Table 81. Global Pain Management Drugs & Devices Consumption Value by Region (2026-2031) & (USD Million)
Table 82. Global Pain Management Drugs & Devices Average Price by Region (2020-2025) & (USD/Unit)
Table 83. Global Pain Management Drugs & Devices Average Price by Region (2026-2031) & (USD/Unit)
Table 84. Global Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 85. Global Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 86. Global Pain Management Drugs & Devices Consumption Value by Type (2020-2025) & (USD Million)
Table 87. Global Pain Management Drugs & Devices Consumption Value by Type (2026-2031) & (USD Million)
Table 88. Global Pain Management Drugs & Devices Average Price by Type (2020-2025) & (USD/Unit)
Table 89. Global Pain Management Drugs & Devices Average Price by Type (2026-2031) & (USD/Unit)
Table 90. Global Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 91. Global Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 92. Global Pain Management Drugs & Devices Consumption Value by Application (2020-2025) & (USD Million)
Table 93. Global Pain Management Drugs & Devices Consumption Value by Application (2026-2031) & (USD Million)
Table 94. Global Pain Management Drugs & Devices Average Price by Application (2020-2025) & (USD/Unit)
Table 95. Global Pain Management Drugs & Devices Average Price by Application (2026-2031) & (USD/Unit)
Table 96. North America Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 97. North America Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 98. North America Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 99. North America Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 100. North America Pain Management Drugs & Devices Sales Quantity by Country (2020-2025) & (K Units)
Table 101. North America Pain Management Drugs & Devices Sales Quantity by Country (2026-2031) & (K Units)
Table 102. North America Pain Management Drugs & Devices Consumption Value by Country (2020-2025) & (USD Million)
Table 103. North America Pain Management Drugs & Devices Consumption Value by Country (2026-2031) & (USD Million)
Table 104. Europe Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 105. Europe Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 106. Europe Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 107. Europe Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 108. Europe Pain Management Drugs & Devices Sales Quantity by Country (2020-2025) & (K Units)
Table 109. Europe Pain Management Drugs & Devices Sales Quantity by Country (2026-2031) & (K Units)
Table 110. Europe Pain Management Drugs & Devices Consumption Value by Country (2020-2025) & (USD Million)
Table 111. Europe Pain Management Drugs & Devices Consumption Value by Country (2026-2031) & (USD Million)
Table 112. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 113. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 114. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 115. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 116. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Region (2020-2025) & (K Units)
Table 117. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Region (2026-2031) & (K Units)
Table 118. Asia-Pacific Pain Management Drugs & Devices Consumption Value by Region (2020-2025) & (USD Million)
Table 119. Asia-Pacific Pain Management Drugs & Devices Consumption Value by Region (2026-2031) & (USD Million)
Table 120. South America Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 121. South America Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 122. South America Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 123. South America Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 124. South America Pain Management Drugs & Devices Sales Quantity by Country (2020-2025) & (K Units)
Table 125. South America Pain Management Drugs & Devices Sales Quantity by Country (2026-2031) & (K Units)
Table 126. South America Pain Management Drugs & Devices Consumption Value by Country (2020-2025) & (USD Million)
Table 127. South America Pain Management Drugs & Devices Consumption Value by Country (2026-2031) & (USD Million)
Table 128. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 129. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 130. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 131. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 132. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Country (2020-2025) & (K Units)
Table 133. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Country (2026-2031) & (K Units)
Table 134. Middle East & Africa Pain Management Drugs & Devices Consumption Value by Country (2020-2025) & (USD Million)
Table 135. Middle East & Africa Pain Management Drugs & Devices Consumption Value by Country (2026-2031) & (USD Million)
Table 136. Pain Management Drugs & Devices Raw Material
Table 137. Key Manufacturers of Pain Management Drugs & Devices Raw Materials
Table 138. Pain Management Drugs & Devices Typical Distributors
Table 139. Pain Management Drugs & Devices Typical Customers


List of Figures
Figure 1. Pain Management Drugs & Devices Picture
Figure 2. Global Pain Management Drugs & Devices Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Pain Management Drugs & Devices Revenue Market Share by Type in 2024
Figure 4. Pharmaceuticals Examples
Figure 5. Devices Examples
Figure 6. Global Pain Management Drugs & Devices Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Pain Management Drugs & Devices Revenue Market Share by Application in 2024
Figure 8. Burn Pain Examples
Figure 9. Cancer Pain Examples
Figure 10. Dental/Facial Pain Examples
Figure 11. Migraine Headache Pain Examples
Figure 12. Musculoskeletal Pain Examples
Figure 13. Neuropathic Pain Examples
Figure 14. Obstetrical Pain Examples
Figure 15. Global Pain Management Drugs & Devices Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 16. Global Pain Management Drugs & Devices Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 17. Global Pain Management Drugs & Devices Sales Quantity (2020-2031) & (K Units)
Figure 18. Global Pain Management Drugs & Devices Price (2020-2031) & (USD/Unit)
Figure 19. Global Pain Management Drugs & Devices Sales Quantity Market Share by Manufacturer in 2024
Figure 20. Global Pain Management Drugs & Devices Revenue Market Share by Manufacturer in 2024
Figure 21. Producer Shipments of Pain Management Drugs & Devices by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 22. Top 3 Pain Management Drugs & Devices Manufacturer (Revenue) Market Share in 2024
Figure 23. Top 6 Pain Management Drugs & Devices Manufacturer (Revenue) Market Share in 2024
Figure 24. Global Pain Management Drugs & Devices Sales Quantity Market Share by Region (2020-2031)
Figure 25. Global Pain Management Drugs & Devices Consumption Value Market Share by Region (2020-2031)
Figure 26. North America Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 27. Europe Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 28. Asia-Pacific Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 29. South America Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 30. Middle East & Africa Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 31. Global Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 32. Global Pain Management Drugs & Devices Consumption Value Market Share by Type (2020-2031)
Figure 33. Global Pain Management Drugs & Devices Average Price by Type (2020-2031) & (USD/Unit)
Figure 34. Global Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 35. Global Pain Management Drugs & Devices Revenue Market Share by Application (2020-2031)
Figure 36. Global Pain Management Drugs & Devices Average Price by Application (2020-2031) & (USD/Unit)
Figure 37. North America Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 38. North America Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 39. North America Pain Management Drugs & Devices Sales Quantity Market Share by Country (2020-2031)
Figure 40. North America Pain Management Drugs & Devices Consumption Value Market Share by Country (2020-2031)
Figure 41. United States Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 42. Canada Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 43. Mexico Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 44. Europe Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 45. Europe Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 46. Europe Pain Management Drugs & Devices Sales Quantity Market Share by Country (2020-2031)
Figure 47. Europe Pain Management Drugs & Devices Consumption Value Market Share by Country (2020-2031)
Figure 48. Germany Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 49. France Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 50. United Kingdom Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 51. Russia Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 52. Italy Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 53. Asia-Pacific Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 54. Asia-Pacific Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 55. Asia-Pacific Pain Management Drugs & Devices Sales Quantity Market Share by Region (2020-2031)
Figure 56. Asia-Pacific Pain Management Drugs & Devices Consumption Value Market Share by Region (2020-2031)
Figure 57. China Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 58. Japan Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 59. South Korea Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 60. India Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 61. Southeast Asia Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 62. Australia Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 63. South America Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 64. South America Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 65. South America Pain Management Drugs & Devices Sales Quantity Market Share by Country (2020-2031)
Figure 66. South America Pain Management Drugs & Devices Consumption Value Market Share by Country (2020-2031)
Figure 67. Brazil Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 68. Argentina Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 69. Middle East & Africa Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 70. Middle East & Africa Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 71. Middle East & Africa Pain Management Drugs & Devices Sales Quantity Market Share by Country (2020-2031)
Figure 72. Middle East & Africa Pain Management Drugs & Devices Consumption Value Market Share by Country (2020-2031)
Figure 73. Turkey Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 74. Egypt Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 75. Saudi Arabia Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 76. South Africa Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 77. Pain Management Drugs & Devices Market Drivers
Figure 78. Pain Management Drugs & Devices Market Restraints
Figure 79. Pain Management Drugs & Devices Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Pain Management Drugs & Devices in 2024
Figure 82. Manufacturing Process Analysis of Pain Management Drugs & Devices
Figure 83. Pain Management Drugs & Devices Industrial Chain
Figure 84. Sales Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Abbvie Inc.
Astrazeneca Depomed Inc.
Djo Global Inc.
Eli Lilly & Co.
Endo International
Glaxosmithkline
Hisamitsu Pharmaceutical Co. Inc.
Johnson & Johnson
Medtronic Inc.
Novartis International Ag
Pfizer
Purdue Pharmaceuticals Lp
Abbott
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Pain Management Drugs & Devices Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Pain Management Drugs & Devices Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Page: 113

Published Date: 02 Jan 2025

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Pain Management Drugs & Devices market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report is a detailed and comprehensive analysis for global Pain Management Drugs & Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Pain Management Drugs & Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pain Management Drugs & Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pain Management Drugs & Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Pain Management Drugs & Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pain Management Drugs & Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pain Management Drugs & Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbvie Inc., Astrazeneca Depomed Inc., Djo Global Inc., Eli Lilly & Co., Endo International, Glaxosmithkline, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic Inc., Novartis International Ag, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Pain Management Drugs & Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Pharmaceuticals
Devices

Market segment by Application
Burn Pain
Cancer Pain
Dental/Facial Pain
Migraine Headache Pain
Musculoskeletal Pain
Neuropathic Pain
Obstetrical Pain

Major players covered
Abbvie Inc.
Astrazeneca Depomed Inc.
Djo Global Inc.
Eli Lilly & Co.
Endo International
Glaxosmithkline
Hisamitsu Pharmaceutical Co. Inc.
Johnson & Johnson
Medtronic Inc.
Novartis International Ag
Pfizer
Purdue Pharmaceuticals Lp
Abbott

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pain Management Drugs & Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pain Management Drugs & Devices, with price, sales quantity, revenue, and global market share of Pain Management Drugs & Devices from 2020 to 2025.
Chapter 3, the Pain Management Drugs & Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pain Management Drugs & Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Pain Management Drugs & Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pain Management Drugs & Devices.
Chapter 14 and 15, to describe Pain Management Drugs & Devices sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pain Management Drugs & Devices Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Pharmaceuticals
1.3.3 Devices
1.4 Market Analysis by Application
1.4.1 Overview: Global Pain Management Drugs & Devices Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Burn Pain
1.4.3 Cancer Pain
1.4.4 Dental/Facial Pain
1.4.5 Migraine Headache Pain
1.4.6 Musculoskeletal Pain
1.4.7 Neuropathic Pain
1.4.8 Obstetrical Pain
1.5 Global Pain Management Drugs & Devices Market Size & Forecast
1.5.1 Global Pain Management Drugs & Devices Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Pain Management Drugs & Devices Sales Quantity (2020-2031)
1.5.3 Global Pain Management Drugs & Devices Average Price (2020-2031)

2 Manufacturers Profiles
2.1 Abbvie Inc.
2.1.1 Abbvie Inc. Details
2.1.2 Abbvie Inc. Major Business
2.1.3 Abbvie Inc. Pain Management Drugs & Devices Product and Services
2.1.4 Abbvie Inc. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Abbvie Inc. Recent Developments/Updates
2.2 Astrazeneca Depomed Inc.
2.2.1 Astrazeneca Depomed Inc. Details
2.2.2 Astrazeneca Depomed Inc. Major Business
2.2.3 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Product and Services
2.2.4 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Astrazeneca Depomed Inc. Recent Developments/Updates
2.3 Djo Global Inc.
2.3.1 Djo Global Inc. Details
2.3.2 Djo Global Inc. Major Business
2.3.3 Djo Global Inc. Pain Management Drugs & Devices Product and Services
2.3.4 Djo Global Inc. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Djo Global Inc. Recent Developments/Updates
2.4 Eli Lilly & Co.
2.4.1 Eli Lilly & Co. Details
2.4.2 Eli Lilly & Co. Major Business
2.4.3 Eli Lilly & Co. Pain Management Drugs & Devices Product and Services
2.4.4 Eli Lilly & Co. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Eli Lilly & Co. Recent Developments/Updates
2.5 Endo International
2.5.1 Endo International Details
2.5.2 Endo International Major Business
2.5.3 Endo International Pain Management Drugs & Devices Product and Services
2.5.4 Endo International Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Endo International Recent Developments/Updates
2.6 Glaxosmithkline
2.6.1 Glaxosmithkline Details
2.6.2 Glaxosmithkline Major Business
2.6.3 Glaxosmithkline Pain Management Drugs & Devices Product and Services
2.6.4 Glaxosmithkline Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Glaxosmithkline Recent Developments/Updates
2.7 Hisamitsu Pharmaceutical Co. Inc.
2.7.1 Hisamitsu Pharmaceutical Co. Inc. Details
2.7.2 Hisamitsu Pharmaceutical Co. Inc. Major Business
2.7.3 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Product and Services
2.7.4 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Hisamitsu Pharmaceutical Co. Inc. Recent Developments/Updates
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Pain Management Drugs & Devices Product and Services
2.8.4 Johnson & Johnson Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Johnson & Johnson Recent Developments/Updates
2.9 Medtronic Inc.
2.9.1 Medtronic Inc. Details
2.9.2 Medtronic Inc. Major Business
2.9.3 Medtronic Inc. Pain Management Drugs & Devices Product and Services
2.9.4 Medtronic Inc. Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Medtronic Inc. Recent Developments/Updates
2.10 Novartis International Ag
2.10.1 Novartis International Ag Details
2.10.2 Novartis International Ag Major Business
2.10.3 Novartis International Ag Pain Management Drugs & Devices Product and Services
2.10.4 Novartis International Ag Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Novartis International Ag Recent Developments/Updates
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Pain Management Drugs & Devices Product and Services
2.11.4 Pfizer Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Pfizer Recent Developments/Updates
2.12 Purdue Pharmaceuticals Lp
2.12.1 Purdue Pharmaceuticals Lp Details
2.12.2 Purdue Pharmaceuticals Lp Major Business
2.12.3 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Product and Services
2.12.4 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Purdue Pharmaceuticals Lp Recent Developments/Updates
2.13 Abbott
2.13.1 Abbott Details
2.13.2 Abbott Major Business
2.13.3 Abbott Pain Management Drugs & Devices Product and Services
2.13.4 Abbott Pain Management Drugs & Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Abbott Recent Developments/Updates

3 Competitive Environment: Pain Management Drugs & Devices by Manufacturer
3.1 Global Pain Management Drugs & Devices Sales Quantity by Manufacturer (2020-2025)
3.2 Global Pain Management Drugs & Devices Revenue by Manufacturer (2020-2025)
3.3 Global Pain Management Drugs & Devices Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Pain Management Drugs & Devices by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Pain Management Drugs & Devices Manufacturer Market Share in 2024
3.4.3 Top 6 Pain Management Drugs & Devices Manufacturer Market Share in 2024
3.5 Pain Management Drugs & Devices Market: Overall Company Footprint Analysis
3.5.1 Pain Management Drugs & Devices Market: Region Footprint
3.5.2 Pain Management Drugs & Devices Market: Company Product Type Footprint
3.5.3 Pain Management Drugs & Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Pain Management Drugs & Devices Market Size by Region
4.1.1 Global Pain Management Drugs & Devices Sales Quantity by Region (2020-2031)
4.1.2 Global Pain Management Drugs & Devices Consumption Value by Region (2020-2031)
4.1.3 Global Pain Management Drugs & Devices Average Price by Region (2020-2031)
4.2 North America Pain Management Drugs & Devices Consumption Value (2020-2031)
4.3 Europe Pain Management Drugs & Devices Consumption Value (2020-2031)
4.4 Asia-Pacific Pain Management Drugs & Devices Consumption Value (2020-2031)
4.5 South America Pain Management Drugs & Devices Consumption Value (2020-2031)
4.6 Middle East & Africa Pain Management Drugs & Devices Consumption Value (2020-2031)

5 Market Segment by Type
5.1 Global Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
5.2 Global Pain Management Drugs & Devices Consumption Value by Type (2020-2031)
5.3 Global Pain Management Drugs & Devices Average Price by Type (2020-2031)

6 Market Segment by Application
6.1 Global Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
6.2 Global Pain Management Drugs & Devices Consumption Value by Application (2020-2031)
6.3 Global Pain Management Drugs & Devices Average Price by Application (2020-2031)

7 North America
7.1 North America Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
7.2 North America Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
7.3 North America Pain Management Drugs & Devices Market Size by Country
7.3.1 North America Pain Management Drugs & Devices Sales Quantity by Country (2020-2031)
7.3.2 North America Pain Management Drugs & Devices Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe
8.1 Europe Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
8.2 Europe Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
8.3 Europe Pain Management Drugs & Devices Market Size by Country
8.3.1 Europe Pain Management Drugs & Devices Sales Quantity by Country (2020-2031)
8.3.2 Europe Pain Management Drugs & Devices Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific
9.1 Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Pain Management Drugs & Devices Market Size by Region
9.3.1 Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Pain Management Drugs & Devices Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America
10.1 South America Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
10.2 South America Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
10.3 South America Pain Management Drugs & Devices Market Size by Country
10.3.1 South America Pain Management Drugs & Devices Sales Quantity by Country (2020-2031)
10.3.2 South America Pain Management Drugs & Devices Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa
11.1 Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Pain Management Drugs & Devices Market Size by Country
11.3.1 Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Pain Management Drugs & Devices Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics
12.1 Pain Management Drugs & Devices Market Drivers
12.2 Pain Management Drugs & Devices Market Restraints
12.3 Pain Management Drugs & Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Pain Management Drugs & Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pain Management Drugs & Devices
13.3 Pain Management Drugs & Devices Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pain Management Drugs & Devices Typical Distributors
14.3 Pain Management Drugs & Devices Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Pain Management Drugs & Devices Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Pain Management Drugs & Devices Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Abbvie Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Abbvie Inc. Major Business
Table 5. Abbvie Inc. Pain Management Drugs & Devices Product and Services
Table 6. Abbvie Inc. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Abbvie Inc. Recent Developments/Updates
Table 8. Astrazeneca Depomed Inc. Basic Information, Manufacturing Base and Competitors
Table 9. Astrazeneca Depomed Inc. Major Business
Table 10. Astrazeneca Depomed Inc. Pain Management Drugs & Devices Product and Services
Table 11. Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Astrazeneca Depomed Inc. Recent Developments/Updates
Table 13. Djo Global Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Djo Global Inc. Major Business
Table 15. Djo Global Inc. Pain Management Drugs & Devices Product and Services
Table 16. Djo Global Inc. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Djo Global Inc. Recent Developments/Updates
Table 18. Eli Lilly & Co. Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly & Co. Major Business
Table 20. Eli Lilly & Co. Pain Management Drugs & Devices Product and Services
Table 21. Eli Lilly & Co. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Eli Lilly & Co. Recent Developments/Updates
Table 23. Endo International Basic Information, Manufacturing Base and Competitors
Table 24. Endo International Major Business
Table 25. Endo International Pain Management Drugs & Devices Product and Services
Table 26. Endo International Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Endo International Recent Developments/Updates
Table 28. Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table 29. Glaxosmithkline Major Business
Table 30. Glaxosmithkline Pain Management Drugs & Devices Product and Services
Table 31. Glaxosmithkline Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Glaxosmithkline Recent Developments/Updates
Table 33. Hisamitsu Pharmaceutical Co. Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Hisamitsu Pharmaceutical Co. Inc. Major Business
Table 35. Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Product and Services
Table 36. Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Hisamitsu Pharmaceutical Co. Inc. Recent Developments/Updates
Table 38. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 39. Johnson & Johnson Major Business
Table 40. Johnson & Johnson Pain Management Drugs & Devices Product and Services
Table 41. Johnson & Johnson Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Johnson & Johnson Recent Developments/Updates
Table 43. Medtronic Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Medtronic Inc. Major Business
Table 45. Medtronic Inc. Pain Management Drugs & Devices Product and Services
Table 46. Medtronic Inc. Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Medtronic Inc. Recent Developments/Updates
Table 48. Novartis International Ag Basic Information, Manufacturing Base and Competitors
Table 49. Novartis International Ag Major Business
Table 50. Novartis International Ag Pain Management Drugs & Devices Product and Services
Table 51. Novartis International Ag Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Novartis International Ag Recent Developments/Updates
Table 53. Pfizer Basic Information, Manufacturing Base and Competitors
Table 54. Pfizer Major Business
Table 55. Pfizer Pain Management Drugs & Devices Product and Services
Table 56. Pfizer Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Pfizer Recent Developments/Updates
Table 58. Purdue Pharmaceuticals Lp Basic Information, Manufacturing Base and Competitors
Table 59. Purdue Pharmaceuticals Lp Major Business
Table 60. Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Product and Services
Table 61. Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Purdue Pharmaceuticals Lp Recent Developments/Updates
Table 63. Abbott Basic Information, Manufacturing Base and Competitors
Table 64. Abbott Major Business
Table 65. Abbott Pain Management Drugs & Devices Product and Services
Table 66. Abbott Pain Management Drugs & Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Abbott Recent Developments/Updates
Table 68. Global Pain Management Drugs & Devices Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 69. Global Pain Management Drugs & Devices Revenue by Manufacturer (2020-2025) & (USD Million)
Table 70. Global Pain Management Drugs & Devices Average Price by Manufacturer (2020-2025) & (USD/Unit)
Table 71. Market Position of Manufacturers in Pain Management Drugs & Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 72. Head Office and Pain Management Drugs & Devices Production Site of Key Manufacturer
Table 73. Pain Management Drugs & Devices Market: Company Product Type Footprint
Table 74. Pain Management Drugs & Devices Market: Company Product Application Footprint
Table 75. Pain Management Drugs & Devices New Market Entrants and Barriers to Market Entry
Table 76. Pain Management Drugs & Devices Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Pain Management Drugs & Devices Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 78. Global Pain Management Drugs & Devices Sales Quantity by Region (2020-2025) & (K Units)
Table 79. Global Pain Management Drugs & Devices Sales Quantity by Region (2026-2031) & (K Units)
Table 80. Global Pain Management Drugs & Devices Consumption Value by Region (2020-2025) & (USD Million)
Table 81. Global Pain Management Drugs & Devices Consumption Value by Region (2026-2031) & (USD Million)
Table 82. Global Pain Management Drugs & Devices Average Price by Region (2020-2025) & (USD/Unit)
Table 83. Global Pain Management Drugs & Devices Average Price by Region (2026-2031) & (USD/Unit)
Table 84. Global Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 85. Global Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 86. Global Pain Management Drugs & Devices Consumption Value by Type (2020-2025) & (USD Million)
Table 87. Global Pain Management Drugs & Devices Consumption Value by Type (2026-2031) & (USD Million)
Table 88. Global Pain Management Drugs & Devices Average Price by Type (2020-2025) & (USD/Unit)
Table 89. Global Pain Management Drugs & Devices Average Price by Type (2026-2031) & (USD/Unit)
Table 90. Global Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 91. Global Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 92. Global Pain Management Drugs & Devices Consumption Value by Application (2020-2025) & (USD Million)
Table 93. Global Pain Management Drugs & Devices Consumption Value by Application (2026-2031) & (USD Million)
Table 94. Global Pain Management Drugs & Devices Average Price by Application (2020-2025) & (USD/Unit)
Table 95. Global Pain Management Drugs & Devices Average Price by Application (2026-2031) & (USD/Unit)
Table 96. North America Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 97. North America Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 98. North America Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 99. North America Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 100. North America Pain Management Drugs & Devices Sales Quantity by Country (2020-2025) & (K Units)
Table 101. North America Pain Management Drugs & Devices Sales Quantity by Country (2026-2031) & (K Units)
Table 102. North America Pain Management Drugs & Devices Consumption Value by Country (2020-2025) & (USD Million)
Table 103. North America Pain Management Drugs & Devices Consumption Value by Country (2026-2031) & (USD Million)
Table 104. Europe Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 105. Europe Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 106. Europe Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 107. Europe Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 108. Europe Pain Management Drugs & Devices Sales Quantity by Country (2020-2025) & (K Units)
Table 109. Europe Pain Management Drugs & Devices Sales Quantity by Country (2026-2031) & (K Units)
Table 110. Europe Pain Management Drugs & Devices Consumption Value by Country (2020-2025) & (USD Million)
Table 111. Europe Pain Management Drugs & Devices Consumption Value by Country (2026-2031) & (USD Million)
Table 112. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 113. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 114. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 115. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 116. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Region (2020-2025) & (K Units)
Table 117. Asia-Pacific Pain Management Drugs & Devices Sales Quantity by Region (2026-2031) & (K Units)
Table 118. Asia-Pacific Pain Management Drugs & Devices Consumption Value by Region (2020-2025) & (USD Million)
Table 119. Asia-Pacific Pain Management Drugs & Devices Consumption Value by Region (2026-2031) & (USD Million)
Table 120. South America Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 121. South America Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 122. South America Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 123. South America Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 124. South America Pain Management Drugs & Devices Sales Quantity by Country (2020-2025) & (K Units)
Table 125. South America Pain Management Drugs & Devices Sales Quantity by Country (2026-2031) & (K Units)
Table 126. South America Pain Management Drugs & Devices Consumption Value by Country (2020-2025) & (USD Million)
Table 127. South America Pain Management Drugs & Devices Consumption Value by Country (2026-2031) & (USD Million)
Table 128. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Type (2020-2025) & (K Units)
Table 129. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Type (2026-2031) & (K Units)
Table 130. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Application (2020-2025) & (K Units)
Table 131. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Application (2026-2031) & (K Units)
Table 132. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Country (2020-2025) & (K Units)
Table 133. Middle East & Africa Pain Management Drugs & Devices Sales Quantity by Country (2026-2031) & (K Units)
Table 134. Middle East & Africa Pain Management Drugs & Devices Consumption Value by Country (2020-2025) & (USD Million)
Table 135. Middle East & Africa Pain Management Drugs & Devices Consumption Value by Country (2026-2031) & (USD Million)
Table 136. Pain Management Drugs & Devices Raw Material
Table 137. Key Manufacturers of Pain Management Drugs & Devices Raw Materials
Table 138. Pain Management Drugs & Devices Typical Distributors
Table 139. Pain Management Drugs & Devices Typical Customers


List of Figures
Figure 1. Pain Management Drugs & Devices Picture
Figure 2. Global Pain Management Drugs & Devices Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Pain Management Drugs & Devices Revenue Market Share by Type in 2024
Figure 4. Pharmaceuticals Examples
Figure 5. Devices Examples
Figure 6. Global Pain Management Drugs & Devices Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Pain Management Drugs & Devices Revenue Market Share by Application in 2024
Figure 8. Burn Pain Examples
Figure 9. Cancer Pain Examples
Figure 10. Dental/Facial Pain Examples
Figure 11. Migraine Headache Pain Examples
Figure 12. Musculoskeletal Pain Examples
Figure 13. Neuropathic Pain Examples
Figure 14. Obstetrical Pain Examples
Figure 15. Global Pain Management Drugs & Devices Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 16. Global Pain Management Drugs & Devices Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 17. Global Pain Management Drugs & Devices Sales Quantity (2020-2031) & (K Units)
Figure 18. Global Pain Management Drugs & Devices Price (2020-2031) & (USD/Unit)
Figure 19. Global Pain Management Drugs & Devices Sales Quantity Market Share by Manufacturer in 2024
Figure 20. Global Pain Management Drugs & Devices Revenue Market Share by Manufacturer in 2024
Figure 21. Producer Shipments of Pain Management Drugs & Devices by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 22. Top 3 Pain Management Drugs & Devices Manufacturer (Revenue) Market Share in 2024
Figure 23. Top 6 Pain Management Drugs & Devices Manufacturer (Revenue) Market Share in 2024
Figure 24. Global Pain Management Drugs & Devices Sales Quantity Market Share by Region (2020-2031)
Figure 25. Global Pain Management Drugs & Devices Consumption Value Market Share by Region (2020-2031)
Figure 26. North America Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 27. Europe Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 28. Asia-Pacific Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 29. South America Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 30. Middle East & Africa Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 31. Global Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 32. Global Pain Management Drugs & Devices Consumption Value Market Share by Type (2020-2031)
Figure 33. Global Pain Management Drugs & Devices Average Price by Type (2020-2031) & (USD/Unit)
Figure 34. Global Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 35. Global Pain Management Drugs & Devices Revenue Market Share by Application (2020-2031)
Figure 36. Global Pain Management Drugs & Devices Average Price by Application (2020-2031) & (USD/Unit)
Figure 37. North America Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 38. North America Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 39. North America Pain Management Drugs & Devices Sales Quantity Market Share by Country (2020-2031)
Figure 40. North America Pain Management Drugs & Devices Consumption Value Market Share by Country (2020-2031)
Figure 41. United States Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 42. Canada Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 43. Mexico Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 44. Europe Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 45. Europe Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 46. Europe Pain Management Drugs & Devices Sales Quantity Market Share by Country (2020-2031)
Figure 47. Europe Pain Management Drugs & Devices Consumption Value Market Share by Country (2020-2031)
Figure 48. Germany Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 49. France Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 50. United Kingdom Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 51. Russia Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 52. Italy Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 53. Asia-Pacific Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 54. Asia-Pacific Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 55. Asia-Pacific Pain Management Drugs & Devices Sales Quantity Market Share by Region (2020-2031)
Figure 56. Asia-Pacific Pain Management Drugs & Devices Consumption Value Market Share by Region (2020-2031)
Figure 57. China Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 58. Japan Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 59. South Korea Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 60. India Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 61. Southeast Asia Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 62. Australia Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 63. South America Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 64. South America Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 65. South America Pain Management Drugs & Devices Sales Quantity Market Share by Country (2020-2031)
Figure 66. South America Pain Management Drugs & Devices Consumption Value Market Share by Country (2020-2031)
Figure 67. Brazil Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 68. Argentina Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 69. Middle East & Africa Pain Management Drugs & Devices Sales Quantity Market Share by Type (2020-2031)
Figure 70. Middle East & Africa Pain Management Drugs & Devices Sales Quantity Market Share by Application (2020-2031)
Figure 71. Middle East & Africa Pain Management Drugs & Devices Sales Quantity Market Share by Country (2020-2031)
Figure 72. Middle East & Africa Pain Management Drugs & Devices Consumption Value Market Share by Country (2020-2031)
Figure 73. Turkey Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 74. Egypt Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 75. Saudi Arabia Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 76. South Africa Pain Management Drugs & Devices Consumption Value (2020-2031) & (USD Million)
Figure 77. Pain Management Drugs & Devices Market Drivers
Figure 78. Pain Management Drugs & Devices Market Restraints
Figure 79. Pain Management Drugs & Devices Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Pain Management Drugs & Devices in 2024
Figure 82. Manufacturing Process Analysis of Pain Management Drugs & Devices
Figure 83. Pain Management Drugs & Devices Industrial Chain
Figure 84. Sales Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Abbvie Inc.
Astrazeneca Depomed Inc.
Djo Global Inc.
Eli Lilly & Co.
Endo International
Glaxosmithkline
Hisamitsu Pharmaceutical Co. Inc.
Johnson & Johnson
Medtronic Inc.
Novartis International Ag
Pfizer
Purdue Pharmaceuticals Lp
Abbott
jiaGou

Add To Cart

gouMai

Buy Now